Hot Features
プレミアム
Myriad Genetics Inc (MYGN)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-14 | Mr. Paul M. BisaroIndependent Director | 7.50k | 27.64k | 買い | 3.69 | 47.65k | 18.68% |
| 2026-05-01 | Mr. Brian DonnellyChief Commercial Officer | -55.98k | 268.68k | Sale to Issuer | 4.80 | 54.04k | -50.88% |
| 2026-04-14 | Mr. Mark S. VerrattiCOO | -1.07k | 5.25k | Sale to Issuer | 4.91 | 629.65k | -0.17% |
| 2026-04-14 | Dr. Dale MuzzeyChief Scientific Officer | -946.00 | 4.64k | Sale to Issuer | 4.91 | 326.31k | -0.29% |
| 2026-03-22 | Mr. Benjamin R. WheelerCFO & Principal Accounting Officer | -549.00 | 2.51k | Sale to Issuer | 4.58 | 298.51k | -0.18% |
| 2026-03-22 | Dr. Dale MuzzeyChief Scientific Officer | -2.02k | 9.25k | Sale to Issuer | 4.58 | 327.26k | -0.61% |
| 2026-03-22 | Mr. Mark S. VerrattiCOO | -2.06k | 9.41k | Sale to Issuer | 4.58 | 630.72k | -0.32% |
| 2026-03-13 | Dr. Kevin Richard Haasインサイダー | -22.31k | 103.96k | Sale to Issuer | 4.66 | 180.02k | -11.03% |
| 2026-03-13 | Ms. Shereen SolaimanCPO | -14.68k | 68.42k | Sale to Issuer | 4.66 | 34.86k | -29.63% |
| 2026-03-13 | Mr. Benjamin R. WheelerCFO & Principal Accounting Officer | -4.75k | 22.14k | Sale to Issuer | 4.66 | 299.06k | -1.56% |
| 2026-03-13 | Mr. Mark S. VerrattiCOO | -29.29k | 136.49k | Sale to Issuer | 4.66 | 632.77k | -4.42% |
| 2026-03-13 | Ms. Jennifer L. FoxChief Legal Officer | -6.00k | 27.94k | Sale to Issuer | 4.66 | 26.06k | -18.70% |
| 2026-03-13 | Dr. Dale MuzzeyChief Scientific Officer | -37.80k | 176.14k | Sale to Issuer | 4.66 | 329.28k | -10.30% |
| 2026-03-13 | Mr. Samraat S. RahaPresident, CEO & Director | -47.12k | 219.58k | Sale to Issuer | 4.66 | 161.98k | -22.54% |
| 2026-03-09 | Mr. Samraat S. RahaPresident, CEO & Director | 40.00k | 199.84k | 買い | 5.00 | 115.43k | 53.03% |
| 2026-03-01 | Ms. Shereen SolaimanCPO | -1.68k | 7.72k | Sale to Issuer | 4.61 | 14.82k | -10.16% |
| 2026-02-25 | Ms. S. Louise PhanstielIndependent Chair of the Board | 104.51k | 494.72k | 買い | 4.66 - 4.80 | 265.27k | 65.01% |
| 2026-01-01 | Dr. Dale MuzzeyChief Scientific Officer | -418.00 | 2.57k | Sale to Issuer | 6.15 | 170.18k | -0.25% |
| 2025-12-25 | Mr. Benjamin R. WheelerCFO & Principal Accounting Officer | -21.00 | 137.55 | Sale to Issuer | 6.55 | 92.63k | -0.02% |
| 2025-12-11 | Mr. Samraat S. RahaPresident, CEO & Director | -29.63k | 216.33k | Sale to Issuer | 7.30 | 75.43k | -28.20% |
| 2025-09-21 | Mr. Mark S. VerrattiCOO | -1.09k | 8.43k | Sale to Issuer | 7.77 | 381.83k | -0.28% |
| 2025-09-21 | Ms. Natalie Munkインサイダー | -962.00 | 7.47k | Sale to Issuer | 7.77 | 45.17k | -2.09% |
| 2025-09-21 | Mr. Benjamin R. WheelerCFO & Principal Accounting Officer | -2.56k | 19.88k | Sale to Issuer | 7.77 | 92.65k | -2.69% |
| 2025-09-21 | Ms. Margaret Anconaインサイダー | -958.00 | 7.44k | Sale to Issuer | 7.77 | 38.91k | -2.40% |
| 2025-09-03 | Ms. Jennifer L. FoxChief Legal Officer | -4.44k | 30.16k | Sale to Issuer | 6.80 | 11.01k | -28.72% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
